Tipranks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry now
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock Comparison5g StocksAirline StocksArtificial Intelligence StocksBank StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChinese StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksCybersecurity StocksElectric Vehicle StocksFAANG StocksGold StocksGrowth StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksRenewable Energy StocksSolar StocksSpace StocksStay-At-Home StocksTech StocksUtility StocksVideo Game StocksVirtual Reality StocksWallStreetBets StocksWork-From-Home Stocks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
Crinetics Pharmaceuticals Stock Analysis & Ratings
Crinetics Pharmaceuticals Stock Analysis Overview
Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
ANALYST RATINGS
CONSENSUS
Strong Buy
Average Price Target : $43.60
BLOGGER OPINIONS
SENTIMENT
N/A
Currently Not Enough Data Available
HEDGE FUND ACTIVITY
TREND
▲ Increased
By 290.7K Shares Last Quarter.
INSIDER ACTIVITY
TREND
▼ Sold Shares
Worth $228.3K over the Last 3 Months
TIPRANKS INVESTORS
SENTIMENT
Very Positive
Last 7 Days ▲4.5% Last 30 Days ▲8.4%
NEWS SENTIMENT
LAST 7 DAYS
Neutral
Bullish 50% Bearish 50%
TECHNICALS
SMA
Positive
20 days / 200 days
MOMENTUM
25.76%
12 Months Change
FUNDAMENTALS
RETURN ON EQUITY
-51.73%
Trailing 12 Months
ASSET GROWTH
4.51%
Trailing 12 Months
CRNX Stock Stats
Previous Close$19
Open$19.21
Bid0 x 0
Ask29.46 x 40
Today’s Range$18.66 - $20.27
52-Week Range$13.83 - $28.95
Volume247.08K
Average Volume285.25K
Market Cap$899.65M
Beta1.34
P/E Ratio-6.8
EPS-2.78
Earnings DateMar 15, 2022
1Y Price Target$43.60
Company Description
Crinetics Pharmaceuticals
Financials
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
Crinetics Pharmaceuticals News
CRNX FAQ
What was Crinetics Pharmaceuticals’s price range in the past 12 months?
Crinetics Pharmaceuticals lowest stock price was $13.83 and its highest was $28.95 in the past 12 months.
What is Crinetics Pharmaceuticals’s market cap?
Crinetics Pharmaceuticals’s market cap is $899.65M.
What is Crinetics Pharmaceuticals’s price target?
The average price target for Crinetics Pharmaceuticals is $43.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $68.00 ,the lowest forecast is $35.00. The average price target represents 130.20% Increase from the current price of $18.94.
The highest analyst price target is $68.00 ,the lowest forecast is $35.00. The average price target represents 130.20% Increase from the current price of $18.94.
What do analysts say about Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
When is Crinetics Pharmaceuticals’s upcoming earnings report date?
Crinetics Pharmaceuticals’s upcoming earnings report date is Mar 15, 2022 which is in 47 days.
How were Crinetics Pharmaceuticals’s earnings last quarter?
Crinetics Pharmaceuticals released its earnings results on Nov 05, 2021. The company reported -$0.73 earnings per share for the quarter, missing the consensus estimate of -$0.716 by -$0.014.
Is Crinetics Pharmaceuticals overvalued?
According to Wall Street analysts Crinetics Pharmaceuticals’s price is currently Undervalued.
Does Crinetics Pharmaceuticals pay dividends?
Crinetics Pharmaceuticals does not currently pay dividends.
What is Crinetics Pharmaceuticals’s EPS estimate?
Crinetics Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Crinetics Pharmaceuticals have?
Crinetics Pharmaceuticals has 47,500,000 shares outstanding.
What happened to Crinetics Pharmaceuticals’s price movement after its last earnings report?
Crinetics Pharmaceuticals reported an EPS of -$0.73 in its last earnings report, missing expectations of -$0.716. Following the earnings report the stock price went up 0.688%.
Which hedge fund is a major shareholder of Crinetics Pharmaceuticals?
Among the largest hedge funds holding Crinetics Pharmaceuticals’s share is Perceptive Advisors LLC. It holds Crinetics Pharmaceuticals’s shares valued at 83M.